dBMEDx Inc is excited to announce a significant funding milestone, having raised $250,000 to further advance its mission of revolutionizing patient care and supporting frontline nurses in the fight against healthcare-acquired infections. This robust capital injection comes at a pivotal time for the company as it continues its journey to enhance its flagship product, the BBS Revolution™, a next-generation bladder scanner specifically engineered for busy healthcare teams. By integrating the precision of ultrasound technology with sophisticated AI image processing and an elegantly simple design, the BBS Revolution™ offers rapid, automated, and noninvasive bladder volume measurements in just three seconds. This breakthrough device not only locates the bladder automatically—eliminating the need for manual aiming—but also minimizes patient discomfort and simplifies disinfection protocols with its wireless probe design.
The recent funding will be strategically utilized to drive further innovation, optimize manufacturing processes, and scale production to meet growing demand in healthcare settings. With enhanced features such as a self-calibration mechanism and streamlined user training requirements, the device is set to play a crucial role in adhering to best practices for CAUTI prevention. This investment underscores the confidence of investors in dBMEDx’s proprietary technology and its potential to transform infection control protocols. As dBMEDx continues to push the boundaries of medical diagnostic tools, the company remains dedicated to empowering healthcare professionals by providing efficient, reliable, and cutting-edge solutions that improve patient outcomes and support the rigorous demands of modern healthcare environments.
.png&w=3840&q=75)
